David Shulkin, MD, former secretary of the U.S. Department of Veterans Affairs, is Sanford Health’s chief innovation officer.
He leads initiatives to advance work in research, Imagenetics, the Sanford Chip, Profile and World Clinic. He helps to drive the health system’s continued clinical development and serves as a strategic advisor on Sanford Health’s national growth strategy and overall public policy efforts.
He is a director on the Sanford International Board and an ambassador for Sanford Health on many of the health system’s domestic and international projects. In addition, he works with others in academia and health care, providing strategic direction and advice on national health care issues.
Dr. Shulkin received his medical degree from the Medical College of Pennsylvania and is a board-certified internist. He completed an internship at Yale University School of Medicine and a residency and fellowship at the University of Pittsburgh Presbyterian Medical Center.
Build a children’s hospital that looks like a castle? Done. Build a better aortic stent? Done. If it’s an innovation that improves health care for patients, we’re interested. We have a history of working on unique projects, and we finish what we start.
Work with a nimble team. We select the best ideas, file the patents, develop the prototypes, create the marketing and go through the regulatory path. We get the data to prove whether the device or therapy is safe. And we understand how to help get these needed innovations to patients faster.
Our fully integrated model allows us to control many aspects of the health care equation. The combination of our health plan, care delivery assets and research facilities allows us to look at risk and investment in new ways — pushing the boundaries of how we provide value to patients.
Look to Sanford Health as your innovations guide. We deliver the necessary support to see your idea through – thanks to our integrated health system, laboratory testing, research and dedicated resources. We have the staffing and the funding to back good ideas.
The integration of Sanford’s breast cancer biomarkers with our Bio-ID biomarker analysis platform provides a unique solution to breast cancer detection and monitoring. This technology could enable the detection of recurrent breast cancer at a stage when it may be more effectively treated and cured.
Collaborating with Dr. Kelly and Sanford Health establishes a strong working relationship for developing much needed new products that improve treatment options and reduce cost of care.
Sanford Health encourages its employees, physicians and researchers to think differently and go beyond the status quo when delivering care to our patients. We are able to bring our ideas to reality by collaborating with organizations to solve challenges in the medical field and improve treatment methods. Our mission is advancing health and healing through innovation, research and the commercialization of Sanford Health’s technologies to improve the human condition.